About this trial
The primary aim of this double-blind randomized controlled trial is to evaluate the effectiveness of an accelerated rehabilitation protocol on knee joint function and quality of life in individuals undergoing TKA compared to conventional rehabilitation in Dali, Yunan, China. The study will include patients aged 50-80 years who are scheduled for primary unilateral TKA. Participants will be randomly assigned to either an accelerated rehabilitation group or conventional rehabilitation group. The primary outcomes will include knee joint function, assessed using the KOOS and quality of life measures using the SF-36 surveys. The study will follow participants for 6 months post-surgery to assess longer-term outcomes. This study will not include individuals undergoing revision TKA or those with severe comorbid conditions. The results will provide critical insights into the role of accelerated rehabilitation in improving post-operative recovery, functional outcomes, and overall quality of life for TKA patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients diagnosed with end-stage knee OA necessitating primary unilateral TKA.
Disqualifiers
History of joint infections, cancer, or inflammatory arthritis.
End-stage OA from rheumatoid or septic arthritis.
Individuals with neurological disorders such as Alzheimer's disease, - Parkinson's disease, stroke.
Individuals who are unable to follow a structured rehabilitation protocol.
Trial design
Parallel
Treatments tested in this trial
Accelerated exercise
BehavioralBased on optimal and accelerated concepts
Routine exercise
BehavioralConventional program
Treatment groups
Trial outcomes
Primary outcomes
Knee injury and Osteoarthritis Outcome Score (KOOS)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.